FDA urges new trial for experimental Huntington's gene therapy AMT-130

Stock Titan·Mar 2

This story is reported by Stock Titan. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

HDSA 2026: New oral therapy headed for pivotal Huntington’s trial

huntingtonsdiseasenews.com·Jun 30

2

The FDA, urged to avoid controversy, creates a new headache with attack against UniQure

STAT·Mar 6

3

US FDA Reverses Course on Regenxbio's Rare-Disease Gene Therapy, Backs Accelerated Approval Bid

U.S. News & World Report·Jun 22

4

BIO 2026: CEO Calls for U.S. Biotech Urgency and International Competitiveness

Genetic Engineering and Biotechnology News·Jun 24

5

'Like talking to a brick wall': Senate hearing takes aim at FDA's rare disease review process

Fierce Biotech·Feb 26

6

Trump administration's embattled FDA vaccine chief is leaving for the second time

NPR·Mar 6

7

Top 5 Huntington’s disease news stories of 2025

huntingtonsdiseasenews.com·Jan 6

8

US FDA responds after surge of criticism over recent drug approvals

India.Com·Mar 9